Bangkok Dusit Medical Services Public Company Limited (BDUUY) Stock

About Bangkok Dusit Medical Services Public Company Limited

Bangkok Dusit Medical Services Public Company Limited (BDMS), alongside its various subsidiaries, is primarily engaged in the operation of healthcare facilities. The company oversees and manages six prominent hospital groups, including the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. Beyond core hospital services, BDMS also offers holistic clinical wellness programs. Its diversified operations encompass hospitality, with investments in hotels and restaurants, as well as the retail of health and cosmetic products. Additionally, BDMS provides a broad spectrum of services such as accounting, health insurance, laboratory testing, investment management, information technology solutions, and professional training. The company further specializes in advanced medical offerings like skin and aesthetic telemedicine, genome sequencing, and air medical transportation. Its business scope also extends to insurance brokerage, facility management, property management, and asset management. Furthermore, BDMS is involved in the manufacturing and distribution of medicines and pharmaceutical products. Its corporate portfolio also includes e-commerce activities and various real estate ventures. Globally, BDMS operates 47 hospitals across Thailand and Cambodia. Established in 1969, the company maintains its headquarters in Bangkok, Thailand.

Bangkok Dusit Medical Services Public Company Limited is headquartered in TH.

Bangkok Dusit Medical Services Public Company Limited (BDUUY) stock trades at $23.41 with a market capitalization of $9.30B. The stock is valued at a price-to-earnings (P/E) ratio of 20.00, price-to-book of 2.83, price-to-sales of 2.79. Over the past 52 weeks the stock has ranged between $20.42 and $32.33, and currently trades 27.6% below its 52-week high. It pays a dividend yielding 6.83%.

On profitability, Bangkok Dusit Medical Services Public Company Limited generates a return on equity (ROE) of 14.90%, return on capital employed of 13.32%, an operating margin of 16.57%, a net profit margin of 13.94%.

Official website: www.bdo.com.ph

Bangkok Dusit Medical Services Public Company Limited by the numbers, 2016–2025

Between 2016 and 2025 Bangkok Dusit Medical Services Public Company Limited reported revenue of $68.0B rising to $106.9B, a change of +57.2% across 10 years. Compounded, revenue has grown 9.4% a year over five years, 5.2% over three, -0.9% over the last twelve months. Net profit rose to $15.2B.

Operating margin went from 16.7% in 2016 to 16.6% in 2025, essentially unchanged. The most recent net margin is 13.94%. On a trailing twelve-month basis to Mar '26, revenue is $112.0B and net profit $15.6B.

Borrowings fell from $31.9B to $17.5B, cash on hand is $8.1B, cash from operations was $22.5B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 13.8% over five years, and was 14.3% in the most recent year.

The share price itself has compounded at 3.2% a year over five years, -4.8% over three, -23.6% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Bangkok Dusit Medical Services Public Company Limited (BDUUY) — frequently asked questions